SomervailleTim Cancer Research UKUnited Kingdom

• Drugging transcription factors: HSF1 and Brachyury
  WorkmanPaul Speaker United Kingdom
• Proffered Paper: Inhibition of WEE1 kinase activity to overcome secondary resistance to targeted therapies in colorectal cancer
  EACR25-0376
  ArenaSabrina Presenter Italy
• Targeting chromatin proteins for therapeutic benefit in haematological malignancy
  SomervailleTim Speaker United Kingdom
• Proffered Paper: Reversing Acidic Immune Suppression in Cancer with PTT-4256, A First-In-Class Small Molecule Inhibitor of GPR65
  EACR25-0553
  CorbinAlastair Presenter United Kingdom
• PP2A inhibitor protein CIP2A is a prime target for TNBC therapy
  WestermarckJukka Speaker Finland

• TABLE 1: How to build your own network
  RisquesRosana Moderator United States
• TABLE 2: Leadership: Experience in combining research with the direction of a research institute
  BardelliAlberto Moderator Italy
• TABLE 3: Leadership: Experience as a team leader and a research center science director
  MarineJean-Christophe Moderator Belgium
• TABLE 5: How to make your research impactful and transferable to the clinic
  GomisRoger Moderator Spain
• TABLE 6: How to build a successful lab environment
  WestermarckJukka Moderator Finland
• TABLE 7: How do you know when you are ready to start your own lab?
  TurajlicSamra Moderator United Kingdom
• TABLE 8: Challenges of setting up a new lab and establishing yourself as a PI in your home country after years abroad
  Luisa CorreiaAna Moderator Portugal
• TABLE 9: The challenges of starting your own lab
  VenkateshHumsa Moderator United States
• TABLE 10: ERC funding opportunities for starting or establishing a research group in the EU or Associated Countries
  Veronica Caraffini Moderator
• TABLE 4: Life of a scientist between research and hospital
  SomervailleTim Moderator United Kingdom